SPECIALITY MEDICINES LIMITED

Healthcare · Pharmaceuticals & Biotechnology

BSE: 544738
₹158.00
▲ 0.00 (0.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
—/100
Weak
Valuation
—/100
Data unavailable
Momentum
75/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
4.73
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive

Ownership

1 of 1 met
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Value and momentum

2 of 3 met
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 151.3000 · High 158.0000
1W return
7.1%
Low 148.0000 · High 164.9500
1M return
5.3%
Low 142.1500 · High 174.1500
52W return
Data unavailable.
Low 142.1500 · High 175.0000
Lifetime High ₹168.0000 (Aug. 6, 2026)
Lifetime Low ₹145.0000 (Sept. 3, 2026)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish0
5D
157.9
10D
156.5
20D
156.0

Delivery and volume

Day avg. delivery
85.7%
Week avg. delivery
69.0%
Month avg. delivery
79.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

155.77
Pivot
First resistance160.23
Second resistance162.47
Third resistance166.93
First support153.53
Second support149.07
Third support146.83
Day RSI50.8
Day MFI64.3
Day MACD0.11
Day MACD signal-0.80

Beta

1M0.22
3M-0.23
1Y-0.23
3Y-0.23

Price change analysis

↑ 5.3%
Over 1 Month
LowHigh
142.15174.15
—
Over 3 Months
LowHigh
142.15175.00
—
Over 6 Months
LowHigh
142.15175.00
—
Over 1 Year
LowHigh
142.15175.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter43.43%
  • FII/FPI0.24%

Largest holders

Data unavailable.

Historical promoter holding

Historical fii holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
4 Jun 2026 NIRAJ RAJNIKANT SHAH Bulk Sell 50,000 210.0000 BSE
4 Jun 2026 PARADISE MOON INVESTMENT FUND-I Bulk Sell 60,000 211.0000 BSE
29 May 2026 BHAVNA HITESH PATEL Bulk Sell 5,000 225.5200 BSE
29 May 2026 NIRAJ RAJNIKANT SHAH Bulk Buy 50,000 207.8500 BSE
29 May 2026 BHAVNA HITESH PATEL Bulk Buy 69,000 208.4200 BSE
29 May 2026 FEROZA ANWAR SHAIKH Bulk Sell 100,000 207.8500 BSE
29 May 2026 AINUL ANWAR SHAIKH Bulk Sell 102,000 207.8500 BSE
29 May 2026 ANWAR MOHAMMED SHAIKH Bulk Sell 112,000 207.9000 BSE
29 May 2026 YASH HITESH PATEL Bulk Buy 200,000 207.8500 BSE
22 May 2026 NEO APEX SHARE BROKING SERVICES LLP Bulk Sell 61,000 208.9500 BSE

All bulk and block deals →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 AGM/EGM Speciality Medicines Ltd - 544738 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
28 Sep 2026 AGM/EGM Speciality Medicines Ltd - 544738 - Shareholder Meeting / Postal Ballot-Outcome of AGM
28 Sep 2026 Insider Trading / SAST Speciality Medicines Ltd - 544738 - Closure of Trading Window
5 Sep 2026 Company Update Speciality Medicines Ltd - 544738 - Announcement under Regulation 30 (LODR)-Newspaper Publication
3 Sep 2026 AGM/EGM Speciality Medicines Ltd - 544738 - Notice Of 5Th Annual General Meeting

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about SPECIALITY MEDICINES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.